Given the well-established role of FOXA1 in mediating AR transcriptional programs in prostate cancer, it is logical to predict that these two proteins also cooperate in molecular apocrine breast cancer to promote AR activation and target gene expression. This evidence concerns the gene AR and breast carcinoma.